Remember
 

$CRVS Corvus Pharmaceuticals announced partner Angel Pharmaceuticals received IND approval for Phase 1/1b clinical trial of ITK inhibitor CPI-818 in China.”


 More than 1 mo ago by corporatealerts  •  Posted on Wednesday, October 27th at 2:04 PM MST  •  0 REACTIONS

 Do You Know the Most Important and Timely Stock Plays During the Trading Week? View Our Power Rankings.
React to the Post Above with Your Unique Insight
 

Global Streams

 
PulseStream
SpecStream
UserStream
Reactions
EchoStream